The Global Whole Genome Amplification (WGA) Market is set for remarkable growth, with the market size projected to exceed USD 6.5 million by 2034. According to industry estimates, the market is expected to generate USD 2.9 million in sales by 2024, registering a robust compound annual growth rate (CAGR) of 8.1% from 2024 to 2034.
Key Market Drivers
The growth of the WGA market is largely attributed to the increasing demand for high-quality genomic data in various research and clinical applications. Whole genome amplification allows for the amplification of the entire genome from a limited sample, providing researchers with more comprehensive genetic information. This has significant implications in fields such as genetic research, diagnostics, forensics, and personalized medicine.
As the importance of genomics continues to rise across a variety of industries, the market for WGA technologies is anticipated to expand, driven by their crucial role in advancing research, improving diagnostic capabilities, and contributing to the development of targeted therapies.
Key Takeaways
- Market Value in 2024: USD 2.9 million
- Projected Market Value by 2034: USD 6.5 million
- CAGR: 8.1% from 2024 to 2034
- Growth Drivers: Increasing demand for comprehensive genomic data, advancements in genome research, and expanding applications across various fields such as diagnostics and personalized medicine.
Regional Insights
- North America: The largest market share, driven by the region’s leadership in genomics research, strong healthcare infrastructure, and significant investments in biotechnology.
- Europe: Steady growth, particularly in countries such as the UK and Germany, due to increasing research initiatives and healthcare advancements.
- Asia-Pacific: Rapid expansion, particularly in countries like China and India, driven by growing research funding, increasing healthcare access, and rising interest in genomic studies.
- Latin America & Middle East/Africa: Emerging markets experiencing gradual adoption of WGA technologies, supported by improving healthcare systems and research capabilities.
Growth Drivers
The demand for whole genome amplification is driven by several factors:
- Increased Genetic Data Collection: The need for comprehensive genetic data to identify and map genes in the human genome is propelling market growth.
- Awareness and Initiatives: Growing awareness about WGA techniques and initiatives to promote these methods are expected to create lucrative opportunities in the market.
- Government Support and Research Funding: Increased government backing for genomic studies and a reduction in sequencing costs are also contributing to market expansion.
Competition Outlook
The whole genome amplification market is poised to experience notable growth in the near future, owing to several factors. One of the main aspects of the dynamic growth is the increasing number of collaborations and partnerships between operating firms, leading to heightened market competition.
The demand for whole genome amplification is anticipated to develop due to the proliferation of product portfolios and strategic initiatives such as mergers and acquisitions, licensing, and partnerships. Such major mergers and acquisitions have further fuelled the growth of the market, contributing to the comprehensive expansion.
For instance
- In April 2024, Takara Bio USA pitched the Shasta Single-Cell System, an automated, high-throughput NGS solution for oncology research, enabling novel biomarker discovery and saving time and costs for researchers.
- In March 2024, BioSkryb Genomics launched ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, utilizing primary template-directed amplification for high-resolution single-cell DNA insights.
A Full Report Overview
Leading Whole Genome Amplification Brands
- GE Healthcare
- Sygnis AG
- Illumina, Inc.
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Eurofins Scientific
- Agilent Technologies, Inc.
- Oxford Nanopore Technologies
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
Key Segments of Market Report
By Product Type:
As per product type, the industry has been segmented into single-cell WGA kits, complete WGA kits, WGA re-amplification kits, WGA and chip DNA kits, and others.
By Application:
The segment is branched into applications for drug discovery and development, disease diagnosis, agriculture, veterinary research, forensics, and others.
By End User:
Pharma and biotech companies, hospitals and clinics, contract research organizations, research and academic institutes, and others mainly utilize the sector.
By Region:
Industry analysis has been carried out in key countries of North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East and Africa.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
